Clene Inc. 2024 10-K: Assets $8.1M, Liabilities $6.4M
Ticker: CLNN · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1822791
| Field | Detail |
|---|---|
| Company | Clene Inc. (CLNN) |
| Form Type | 10-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, pharmaceuticals, warrants
TL;DR
Clene Inc. 2024 10-K: $8.1M assets, $6.4M liabilities. Net loss reported.
AI Summary
Clene Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting total assets of $8,089,565 and total liabilities of $6,421,084. The company's financial statements indicate a net loss for the period. Clene Inc. is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides a year-end financial snapshot of Clene Inc., detailing its assets, liabilities, and operational status, which is crucial for investors and stakeholders to assess the company's financial health and future prospects.
Risk Assessment
Risk Level: medium — The company reported a net loss, and the filing details significant warrant obligations, indicating potential dilution and financial risk.
Key Numbers
- $8.09B — Total Assets (As of December 31, 2024)
- $6.42B — Total Liabilities (As of December 31, 2024)
- 2,500,000 — Tranche B Warrants (Underlying shares of Common Stock, unexercised as of Dec 31, 2024)
Key Players & Entities
- Clene Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 8,089,565 (dollar_amount) — Total assets as of December 31, 2024
- 6,421,084 (dollar_amount) — Total liabilities as of December 31, 2024
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- DE (state) — State of incorporation
FAQ
What was Clene Inc.'s net income or loss for the fiscal year ended December 31, 2024?
The filing indicates a net loss for the fiscal year ended December 31, 2024, though the specific dollar amount is not explicitly stated in the provided snippet.
How many shares of Common Stock are underlying the Tranche B Warrants?
There are 2,500,000 shares of Common Stock underlying the Tranche B Warrants.
Have any warrants been exercised by December 31, 2024?
No, as of December 31, 2024, no warrants had been exercised.
What is Clene Inc.'s Standard Industrial Classification code?
Clene Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What was the former name of Clene Inc. and when did the name change occur?
The former name was Chelsea Worldwide Inc., and the name change occurred on August 27, 2020.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding Clene Inc. (CLNN).